Allgens Medical Technology Stock Price To Earnings To Growth
| 688613 Stock | 19.16 0.67 3.62% |
Allgens Medical Technology fundamentals help investors to digest information that contributes to Allgens Medical's financial success or failures. It also enables traders to predict the movement of Allgens Stock. The fundamental analysis module provides a way to measure Allgens Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Allgens Medical stock.
Allgens | Price To Earnings To Growth |
Allgens Medical Technology Company Price To Earnings To Growth Analysis
Allgens Medical's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Allgens Medical Technology has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all China stocks is 100.0% higher than that of the company.
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Allgens Fundamentals
| Return On Equity | 3.0E-4 | ||||
| Return On Asset | -0.0136 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 1.59 B | ||||
| Shares Outstanding | 135.55 M | ||||
| Shares Owned By Insiders | 42.74 % | ||||
| Shares Owned By Institutions | 2.38 % | ||||
| Price To Book | 1.83 X | ||||
| Price To Sales | 13.58 X | ||||
| Revenue | 226.48 M | ||||
| Gross Profit | 204.53 M | ||||
| EBITDA | (12.88 M) | ||||
| Net Income | 54.23 M | ||||
| Total Debt | 5.07 M | ||||
| Book Value Per Share | 10.49 X | ||||
| Cash Flow From Operations | 51.68 M | ||||
| Earnings Per Share | 0.04 X | ||||
| Number Of Employees | 202 | ||||
| Beta | 0.51 | ||||
| Market Capitalization | 2.6 B | ||||
| Total Asset | 1.53 B | ||||
| Retained Earnings | 275.99 M | ||||
| Working Capital | 1.15 B | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 1.53 B | ||||
| Last Dividend Paid | 0.06 |
About Allgens Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Allgens Medical Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allgens Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allgens Medical Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Allgens Stock
Allgens Medical financial ratios help investors to determine whether Allgens Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allgens with respect to the benefits of owning Allgens Medical security.